EU seeks feedback on Sanofi's commitments addressing suspected anti-competitive behaviour
EU seeks feedback on Sanofi's commitments addressing suspected anti-competitive behaviour BRUSSELS, July 8 (Reuters) - The European Commission said on Wednesday it would seek feedback on commitments offered by French pharmaceutical company Sanofi SASY.PA to address concerns that it may have breached competition rules in a flu vaccine marketing campaign.
The Commission opened an investigation two weeks ago into whether Sanofi had carried out a misleading campaign to sell its "Efluelda" flu vaccine while disparaging a rival one called "Fluad" made by CSL Seqirus CSL.AX, primarily in France and Germany.
To address the Commission concerns, Sanofi offered a series of commitments, such as publishing statements on its website, that would remain in force until 2030.
(Reporting by Inti Landauro; editing by Foo Yun Chee)
Recent news on Sanofi SA
See all newsEdenTree fund manager Hiorns has bought up French stocks despite civil unrest (updated)
Early US flu season, current strain may signal risk for younger people; doctors urge shots
Brief: Sanofi Starts Work On Insulin Facility In Germany
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Europe Research Roundup: AJ Bell, CMC Markets, Nestle